Science Matters: Setting The Stage For Using Wearables In Oncology Drug Development

Applications in oncology are moving at a more deliberate pace owing to the distinctive nature of cancer patients’ needs. Less impetus to develop novel digital outcomes measures also exists in oncology as tumor-associated outcomes rule the roost. Conversely, the toxic nature of cancer treatments, the duration of treatment, and the variety of drugs and therapeutic regimens available for the many different cancer subtypes elevates the need for objective quality of life (QoL) assessments, where wearables can play an important role.

“Wearables give us insight into patient experiences that we don’t have otherwise, because the data is so objective and dynamic and is acquired when the patients are not under our...